New Strong Buy Stocks for November 21st

Zacks Equity Research Published on November 21, 2023

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aquestive Therapeutics, Inc. (AQST - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 72% over the last 60 days.

Rubicon Technologies, Inc. (RBT - Free Report) : This cloud-based waste and recycling solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 69% over the last 60 days.

Harpoon Therapeutics, Inc. : This immunotherapy company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.2% over the last 60 days.

Viad Corp (VVI - Free Report) : This leisure travel and events experience company has seen the Zacks Consensus Estimate for its current year earnings increasing 140% over the last 60 days.

Avalo Therapeutics, Inc. (AVTX - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Top 5 ChatGPT Stocks Revealed

Zacks Senior Stock Strategist, Kevin Cook names 5 hand-picked stocks with sky-high growth potential in a brilliant sector of Artificial Intelligence. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.

Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. As one of the selected companies puts it, “Automation frees people from the mundane so they can accomplish the miraculous.”